PRINCIPAL GHEALTH-A invests in the master fund กองทุนที่ลงทุนหลายกอง (Schroder International Selection Fund Health, AB International Health Care Portfolio). Actual total expense ratio (TER) 1.97% a year. Pays no dividends. Data as of 13 Nov 2026.
Principal Global Health Innovation Fund
Shows where this fund stands in its group. Not investment advice · Data as of 16 Nov 2026
PRINCIPAL GHEALTH-A is a fund of funds that puts 100.85% into units of other funds, spread across several funds
This fund's manager selects the funds and adjusts their weights. The funds it holds also charge their own fees
All funds, as disclosed in the AMC fact sheet · The stocks these funds hold are shown below · This fund's performance therefore depends on the funds it holds
Over the past year it was in the bottom 25% of its group; over 5 years it returned −8.55% per year (Bottom 25% of the group)
| Return | SD | MDD | Return/SD | |
|---|---|---|---|---|
| YTD | +8.84% | −10.72% | ||
| 1D | −0.48% | −0.48% | ||
| 1W | +2.44% | −0.48% | ||
| 2W | +0.80% | −2.67% | ||
| 1M | +8.82% | −2.67% | ||
| 3M | +5.79% | −5.91% | ||
| 6M | +17.32% | −5.91% | ||
| 1Y | +10.55% | 12.51% | −10.72% | +0.84 |
| 3Y | +17.66%+5.57%/yr | 12.24% | −23.29% | +0.46 |
| 5Y | −36.03%−8.55%/yr | 16.67% | −50.27% | −0.51 |
| MAX | −44.72%−9.76%/yr | 17.63% | −58.50% | −0.55 |
| Return | MDD | SD | Return/SD | |
|---|---|---|---|---|
| YTD | +8.84% | −10.72% | ||
| 1D | −0.48% | −0.48% | ||
| 1W | +2.44% | −0.48% |
Past performance is not a guarantee of future results
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.3 | +0.9 | −7.1 | −0.1 | +2.4 | +6.7 | −0.1 | +1.8 |
Largest drawdown in the selected period −58.50% Previous peak 16 Feb 2021 (NAV 10.3569) → Trough 8 Aug 2025 (NAV 4.2982) · Not back to the previous peak as of 13 Nov 2026
Currently −46.63% from the peak NAV of 10.3569 (16 Feb 2021)
Over 5 years, PRINCIPAL GHEALTH-A returned -0.51 per unit of SD, ranking 45 of 46 funds · The highest is FP HCARE-A (0.49)
กองทุนจะลงทุนในหรือมีไว้ซึ่งหน่วยลงทุนของกองทุนรวม และ/หรือ กองทุน Exchange Traded Fund (ETF) ต่างประเทศที่มีนโยบายลงทุนในตราสารทุนและ/หรือหลักทรัพย์ของบริษัทที่มีการทำธุรกิจที่เกี่ยวข้องหรือได้รับประโยชน์จากธุรกิจที่เกี่ยวข้องกับสุขภาพ (Healthcare) Its largest holdings are Dollar Schroder International Selection Fund Healthcare Innovation (Class C acc USD) : SHCINNC LX 71.01% · AB INTERNATIONAL HEALTH CARE PORTFOLIO (Class I USD Shares) : ACMHCII LX 29.84% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 3 Feb 2021, its NAV has fallen as much as −58.50% from its peak.
Actual total expense ratio (TER) 1.97% a year, against a ceiling of 6.22%. Management fee 1.61%. Front-end fee 1.50%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:00, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 77.31% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · PRINCIPAL GHEALTH-A: no dividends, TER 1.97% · PRINCIPAL GHEALTH-C: see the conditions in the prospectus · PRINCIPAL GHEALTH-D: see the conditions in the prospectus · PRINCIPAL GHEALTH-E: see the conditions in the prospectus · PRINCIPAL GHEALTH-I: see the conditions in the prospectus · PRINCIPAL GHEALTH-R: see the conditions in the prospectus · PRINCIPAL GHEALTH-X: see the conditions in the prospectus
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
Diabetes and weight-loss drugs
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Based on each ETF's actual share of the fund's value · Weighted by each fund held × the stocks that fund holds, covering 101% of the money invested in other funds. Uses each fund's top 10, so figures are a minimum · Schroder International Selection Fund Health as of 31 Oct 2026 · AB International Health Care Portfolio · Illustrations are for explanation only, not individual stock recommendations
| 2W | +0.80% | −2.67% |
| 1M | +8.82% | −2.67% |
| 3M | +5.79% | −5.91% |
| 6M | +17.32% | −5.91% |
| 1Y | +10.55% | −10.72% | 12.51% | +0.84 |
| 3Y | +17.66%+5.57%/yr | −23.29% | 12.24% | +0.46 |
| 5Y | −36.03%−8.55%/yr | −50.27% | 16.67% | −0.51 |
| MAX | −44.72%−9.76%/yr | −58.50% | 17.63% | −0.55 |
No. 1 is SCBGENOME(E) +49.91%
No. 1 is TBIOTECH +23.13% per year
No. 1 is TBIOTECH +7.82% per year
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 16 Nov 2026
| −2.2 |
| +7.5 |
| +0.8 |
| · |
| +8.8* |
| 2025 | +5.2 | −1.1 | −4.0 | −2.0 | −3.2 | +0.8 | −1.9 | +2.1 | +0.8 | +4.5 | +7.5 | −1.1 | +7.2 |
|---|
| 2024 | +2.6 | +3.6 | +1.9 | −5.2 | +2.5 | +2.1 | +0.3 | +4.0 | −4.6 | −3.6 | −1.3 | −6.9 | −5.1 |
|---|
| 2023 | −0.0 | −2.4 | +1.3 | +3.0 | −2.7 | +3.2 | −0.4 | +0.6 | −3.5 | −5.1 | +4.5 | +3.9 | +2.0 |
|---|
| 2022 | −21.9 | −0.8 | +3.5 | −14.5 | −6.1 | −2.4 | +5.0 | −5.7 | −5.0 | +7.7 | +1.2 | −1.8 | −36.7 |
|---|
| Average | −3.1 | −0.8 | −2.5 | −1.3 | −2.2 | +3.6 | +0.1 | +0.6 | −3.5 | +1.7 | +0.8 | −2.4 | −8.2 |
|---|